Anaemia in chronic inflammatory disease of the intestines, an often underestimated problem;Anäimie bei chronisch entzündlichen darmerkrankungen: Ein oft unterschätztes problem

Deutsche Medizinische Wochenschrift

Volumn 127, Issue 15, 2002, Pages 805-808

  Dejaco, C ^a   Gasche, Christoph ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FERROUS GLUCONATE; IRON DEXTRAN; IRON SACCHARATE; RECOMBINANT ERYTHROPOIETIN; IRON;

ANEMIA; CHRONIC INFLAMMATION; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; HEMATOCRIT; HUMAN; REVIEW; ULCERATIVE COLITIS; CHRONIC DISEASE; FEMALE; IRON DEFICIENCY ANEMIA; MALE; METABOLISM;

ANEMIA, IRON-DEFICIENCY; CHRONIC DISEASE; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; IRON; MALE;

EID: 0037066313     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-25048     Document Type: Review

References (18)

1. Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine
2. Identifying hemoglobin level for optimal quality of life: Results of an incremental analysis
3. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
4. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study
5. Recombinant human erythropoietin for treatment of anemia of chronic disease in children with Crohn's disease
6. Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial
7. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin
8. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia
9. Treatment of anemia in inflammatory bowel disease with recombinant human erythropoietin: Results in three patients
10. Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin
11. Symptomatology of anemia
12. Quality of life and anemia: The nephrology experience
13. An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP)
14. Iron and inflammatory bowel disease
15. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency
16. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease
17. Iron deficiency in inflammatory bowel disease. Diagnostic efficacy of serum ferritin
18. »Oversaturation« of transferrin after intravenous ferric gluconate (Ferrlecit(R)) in haemodialysis patients